Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Brandt

Showing results (251-260 of 285) with videos related to

Pageof 29
Sort By:
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 21, 2021
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disordersSusanna Asseyer, Hiroki Masuda, Masahiro Mori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2018
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal studyFrederike C Oertel, Joachim Havla, Adriana Roca-Fernández, et al.
Journal of Neuroinflammation|May 2, 2021
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorderPatrick Schindler, Ulrike Grittner, Johanna Oechtering, et al.
Neuroimage. Clinical|March 18, 2021
Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal studyAthina Papadopoulou, Frederike C Oertel, Claudia Chien, et al.
JAMA Neurology|May 1, 2018
Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated SyndromeHanna G Zimmermann, Benjamin Knier, Timm Oberwahrenbrock, et al.
Multiple Sclerosis and Related Disorders|September 1, 2022
Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorderTing-Yi Lin, Patrick Schindler, Ulrike Grittner, et al.
Journal of Neurology|December 4, 2025
Anchor-based evaluation of digital motor biomarkers from a 2-year observation in 100 patients with multiple sclerosisCarla A Ellinghaus, Hanna M Röhling, Eva-Maria Dorsch, et al.
Annals of Clinical and Translational Neurology|May 19, 2021
Artificial intelligence extension of the OSCAR-IB criteriaAxel Petzold, Philipp Albrecht, Laura Balcer, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patientsFlorence Pache, Hanna Zimmermann, Janine Mikolajczak, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 6, 2023
Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal CohortFrederike Cosima Oertel, Julia Krämer, Seyedamirhosein Motamedi, et al.
Pageof 29

Showing results (251-260 of 285) with videos related to

Sort By:
Pageof 29
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 21, 2021
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disordersSusanna Asseyer, Hiroki Masuda, Masahiro Mori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2018
Retinal ganglion cell loss in neuromyelitis optica: a longitudinal studyFrederike C Oertel, Joachim Havla, Adriana Roca-Fernández, et al.
Journal of Neuroinflammation|May 2, 2021
Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorderPatrick Schindler, Ulrike Grittner, Johanna Oechtering, et al.
Neuroimage. Clinical|March 18, 2021
Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal studyAthina Papadopoulou, Frederike C Oertel, Claudia Chien, et al.
JAMA Neurology|May 1, 2018
Association of Retinal Ganglion Cell Layer Thickness With Future Disease Activity in Patients With Clinically Isolated SyndromeHanna G Zimmermann, Benjamin Knier, Timm Oberwahrenbrock, et al.
Multiple Sclerosis and Related Disorders|September 1, 2022
Serum glial fibrillary acidic protein correlates with retinal structural damage in aquaporin-4 antibody positive neuromyelitis optica spectrum disorderTing-Yi Lin, Patrick Schindler, Ulrike Grittner, et al.
Journal of Neurology|December 4, 2025
Anchor-based evaluation of digital motor biomarkers from a 2-year observation in 100 patients with multiple sclerosisCarla A Ellinghaus, Hanna M Röhling, Eva-Maria Dorsch, et al.
Annals of Clinical and Translational Neurology|May 19, 2021
Artificial intelligence extension of the OSCAR-IB criteriaAxel Petzold, Philipp Albrecht, Laura Balcer, et al.
Journal of Neuroinflammation|November 3, 2016
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patientsFlorence Pache, Hanna Zimmermann, Janine Mikolajczak, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 6, 2023
Visually Evoked Potential as Prognostic Biomarker for Neuroaxonal Damage in Multiple Sclerosis From a Multicenter Longitudinal CohortFrederike Cosima Oertel, Julia Krämer, Seyedamirhosein Motamedi, et al.
Pageof 29